(2020). Amphotericin-b/dexamethasone/tocilizumab: Bronchopleural fistula, Rhizopus-associated mucormycosis and lack of efficacy: case report. Reactions Weekly.
Citação norma Chicago"Amphotericin-b/dexamethasone/tocilizumab: Bronchopleural Fistula, Rhizopus-associated Mucormycosis and Lack of Efficacy: Case Report." Reactions Weekly 2020.
Deismireacht MLA"Amphotericin-b/dexamethasone/tocilizumab: Bronchopleural Fistula, Rhizopus-associated Mucormycosis and Lack of Efficacy: Case Report." Reactions Weekly 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.